Do investors value the FDA orphan drug designation?

Overview of attention for article published in Orphanet Journal of Rare Diseases, June 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news: 1 news outlet
policy: 1 policy source

twitter: 11 X users
facebook: 1 Facebook page

Citations

dimensions_citation: 20 Dimensions

Readers on

mendeley: 79 Mendeley

Summary News Policy documents X Facebook Dimensions citations

So far, Altmetric has seen 1 policy document that references this research output.

Effects of supplementary protection mechanisms for pharmaceutical products

Cited by rijksoverheid.nl on 01 May 2018

rijksoverheid.nl is a searchable database of documents produced by the Dutch government.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.